Literature DB >> 20376454

[Coats disease].

B Junker1, L L Hansen.   

Abstract

Coats disease is characterized by idiopathic congenital retinal telangiectasis and exudative retinopathy. Mostly young males are affected. The disease is usually unilateral. Visual prognosis varies from full visual acuity to blindness according to the extent of retinal exudation. Retinoblastoma is a major differential diagnosis particularly in small children but other causes of exudative retinopathy must also be considered. Treatment aims include obliteration of the telangiectasis in order to resolve retinal exudation and achieve reattachment of the retina. Therapeutic options comprise laser coagulation or cryotherapy, drainage of subretinal fluid, buckling surgery and pars plana vitrectomy. In more advanced cases with therapy-resistant secondary glaucoma enucleation may be required. More recently, intravitreal administration of VEGF inhibitors has become an option.

Entities:  

Mesh:

Year:  2010        PMID: 20376454     DOI: 10.1007/s00347-010-2151-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  22 in total

1.  Telangiectasis of the retina and Coats' disease.

Authors:  A B REESE
Journal:  Am J Ophthalmol       Date:  1956-07       Impact factor: 5.258

2.  Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease.

Authors:  Chris S Bergstrom; G Baker Hubbard
Journal:  Retina       Date:  2008-03       Impact factor: 4.256

3.  Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1971-04       Impact factor: 5.258

4.  Pathogenesis and therapy of traction detachment in various retinal vascular diseases.

Authors:  R Machemer; J M Williams
Journal:  Am J Ophthalmol       Date:  1988-02-15       Impact factor: 5.258

5.  The effect of intravitreal bevacizumab in the treatment of Coats disease in children.

Authors:  Chun-Ju Lin; Jiunn-Feng Hwang; Yan-Ting Chen; San-Ni Chen
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

6.  Spontaneous regression of retinal lesions in Coats' disease.

Authors:  T A Deutsch; M F Rabb; L M Jampol
Journal:  Can J Ophthalmol       Date:  1982-08       Impact factor: 1.882

7.  An animal model for Norrie disease (ND): gene targeting of the mouse ND gene.

Authors:  W Berger; D van de Pol; D Bächner; F Oerlemans; H Winkens; H Hameister; B Wieringa; W Hendriks; H H Ropers
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

8.  Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

9.  Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture.

Authors:  J A Shields; C L Shields; H Ehya; R C Eagle; P De Potter
Journal:  Ophthalmology       Date:  1993-11       Impact factor: 12.079

10.  Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.

Authors:  Young Sun; Atul Jain; Darius M Moshfeghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-07       Impact factor: 3.117

View more
  3 in total

1.  Retinoblastoma in a young adult mimicking Coats' disease.

Authors:  Zheng Zhang; Ji-Tong Shi; Ning-Li Wang; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

2.  [Adjuvant anti-VEGF therapy in Coats' disease].

Authors:  M Fiorentzis; E Stavridis; B Seitz; A Viestenz
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

3.  Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.

Authors:  Xuan Cai; Peiquan Zhao; Qi Zhang; Haiying Jin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-21       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.